4//SEC Filing
Ghosh Anirvan 4
Accession 0000950170-25-047731
CIK 0001463361other
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 4:15 PM ET
Size
7.8 KB
Accession
0000950170-25-047731
Insider Transaction Report
Form 4
Ghosh Anirvan
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-28+286,000→ 286,000 totalExercise: $1.67Exp: 2035-03-27→ Common Stock (286,000 underlying) - Award
Common Stock, $0.0001 par value
2025-03-28+175,000→ 250,251 total
Footnotes (3)
- [F1]On January 30, 2024, the Board of Directors granted the Reporting Person 175,000 Restricted Stock Units ("RSUs") that vest in full upon the satisfaction of certain performance criteria, which were met on March 28, 2025.
- [F2]Includes RSUs that vest over time measured from the grant date.
- [F3]On January 30, 2024, the Board of Directors granted the Reporting Person an option to purchase 286,000 shares of common stock. The underlying shares vest and become exercisable pursuant to the following schedule: one half of the shares subject to the option vest upon the satisfaction of certain performance criteria, which were met on March 28, 2025, and the remaining shares subject to the option vest in 12 successive, equal monthly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Documents
Issuer
Unity Biotechnology, Inc.
CIK 0001463361
Entity typeother
Related Parties
1- filerCIK 0001807437
Filing Metadata
- Form type
- 4
- Filed
- Mar 30, 8:00 PM ET
- Accepted
- Mar 31, 4:15 PM ET
- Size
- 7.8 KB